News

Boston-Based Startup Debuts First-of-its-Kind Platform Automating RFP Process for Clinical Trial Sponsors and Service Providers

With the increasing challenges associated with bringing a medical product to market, and skyrocketing R&D costs, there has been a shift in biopharmaceutical commercialization and clinical trial strategies in order to minimize risk and maximize success.

Mi-Co has been named a recipient of the 2013 Microsoft Life Sciences Innovation Award for its work in helping a Federal Organization go paperless in clinical trial data capture using Tablets, with its leading Mi-Forms mobile-forms software.

Trial Design: Risk-based Approaches: Best Practices for Ensuring Clinical Data Quality Regulatory: Clinical Research SOPs Also in this issue: Transparency in Europe Fragmented Study Conduct Landscape Comprehensive Evidence Development

Partners take aim at the inefficient research site evaluation system

Strategic alliance delivering integrated, portal-based collaboration tools to streamline clinical trial management and study start-up for biopharmaceutical clients

Clinical Site Services International (CSSi), the leader in global patient enrollment solutions for the clinical research industry, is pleased to announce their new partnership with TruBios.

MedNet Solutions, a global life sciences technology company specializing in clinical study management systems, is pleased to announce that Advance Research Associates (ARA), a CRO dedicated to delivering high quality data management and biostatistical services, has selected iMedNet EDC as its preferred eClinical solution.

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of PAREXEL Functional Services within the Company?s Clinical Research Services business segment.

PRA International(?PRA?), a leading clinical research organization,today announced that funds managed by KKR, a leading global investment firm, are acquiring PRA from Genstar Capital, LLC (?Genstar?), a private equity firm based in San Francisco.

Genetic Alliance, a non-profit health advocacy organization committed to enabling individuals to be full participants in clinical research, is joining the Oracle Health Sciences Network to create a bridge linking individuals in its crowd-sourced patient registry to clinical trials.

INC ResearchLLC, a therapeutically focused global clinical research organization (CRO) with a Trusted Process? for delivering reliable results, today announced it has attained four new accreditations in the Medidata Clinical Cloud?, further reinforcing its focus on innovation to help biopharmaceutical companies overcome critical cost, risk and efficiency challenges across the clinical chain.

ACM Global Central Laboratory, a central lab that specializes in delivering high quality testing services designed to optimize clinical trial outcomes, has renewed its College of American Pathologists (CAP) accreditation based on the results of a recent onsite inspection.

Greenphire, a provider of payment technologies for the clinical trials industry, announced a relationship with Oracle Health Sciences.

The WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services for human research, announced that it has partnered with UL Quality, Compliance and Learning (formerly EduNeering), a provider of technology-driven compliance learning solutions to bring educational opportunities to clinical research professionals.

Gamification is the application of game elements and game design techniques to non-game problems.

Novotech, Australia?s largest clinical CRO has expanded its Asia reach into Hong Kong and the Philippines, building on its established network which already includes a presence in Singapore, South Korea, Taiwan, Thailand, India and Malaysia.

Next week at DIA, two of TransCelerate?s Risk Based Monitoring workstream members will take their newly released methodology to the people.

TransCelerate BioPharma Inc. ("TransCelerate") today announced that it has reached several important milestones in its initiative to realize efficiencies across clinical trial investigator and site qualification and training ("SQT") efforts.

Senior clinical executives from top pharmaceutical companies, including AstraZeneca and GlaxoSmithKline (GSK), alongside leading contract research organizations and representatives from the Association of Clinical Research Professionals (ACRP) and CenterWatch, met recently to set the quality standards and define the competencies for a global competition to recognize and encourage talented researchers in North and South America.